siRNA therapy decreases triglycerides in individuals with uncommon condition

.RESEARCH EMPHASIZE.19 September 2024.

Plozasiran reduced triglyceride degrees through 80% and decreased the threat of pancreatitis in patients with constant chylomicronemia, with or even without a hereditary prognosis.